These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 136871

  • 1. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S.
    Acta Med Okayama; 1976 Jun; 30(3):197-208. PubMed ID: 136871
    [Abstract] [Full Text] [Related]

  • 2. Experimental studies of tumor immunotherapy. I. Macrophage migration inhibitory activity as an immunological parameter.
    Hayashi S.
    Acta Med Okayama; 1976 Apr; 30(2):95-106. PubMed ID: 135489
    [Abstract] [Full Text] [Related]

  • 3. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 4. Nonspecific resistance to tumor allograft.
    Rejthar A, Wotke J, Rejtharová A, Jasková J.
    Neoplasma; 1975 Jul; 22(3):273-8. PubMed ID: 1099469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Macrophage function in tumor-bearing mice: tumoricidal and chemotactic responses of macrophages activated by infection with Mycobacterium bovis, strain BCG.
    Meltzer MS, Stevenson MM.
    J Immunol; 1977 Jun; 118(6):2176-81. PubMed ID: 325142
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Destruction of tumor cells by BCG-activated alqolar macrophages.
    Zwilling BS, Campolito LB.
    J Immunol; 1977 Sep; 119(3):838-41. PubMed ID: 330756
    [Abstract] [Full Text] [Related]

  • 10. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
    Tokunaga T, Kataoka T, Nakamura RM, Yamamoto S, Tanaka T.
    Jpn J Med Sci Biol; 1973 Apr; 26(2):71-85. PubMed ID: 4585343
    [No Abstract] [Full Text] [Related]

  • 11. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice.
    Yumura M.
    Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687
    [Abstract] [Full Text] [Related]

  • 12. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G, Weiner R, Pouillart P, Schwarzenberg L, Jasmin C, Schneider M, Hayat M, Amiel JL, de Vassal F, Rosenfeld C.
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract] [Full Text] [Related]

  • 13. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
    [No Abstract] [Full Text] [Related]

  • 14. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
    Kosugi A, Fujiwara H, Hamaoka T.
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
    [Abstract] [Full Text] [Related]

  • 15. Immunological intervention in neoplasia.
    Weiss DW.
    Johns Hopkins Med J Suppl; 1974 Aug; 3():131-56. PubMed ID: 4371312
    [No Abstract] [Full Text] [Related]

  • 16. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC, Silverstein MJ, Hunt JS, O'Connell TX, Lee YT, Pilch YH, Haskell CM, Morton DL.
    Johns Hopkins Med J Suppl; 1974 Aug; 3():103-20. PubMed ID: 4609024
    [No Abstract] [Full Text] [Related]

  • 17. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
    [No Abstract] [Full Text] [Related]

  • 18. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G, Gittel H, Ben-Efraim S.
    Anticancer Res; 1994 Dec; 14(3A):1083-7. PubMed ID: 8074454
    [Abstract] [Full Text] [Related]

  • 19. Mycobacterial cell wall components in tumor suppression and regression.
    Ribi EE, Meyer TJ, Azuma I, Zbar B.
    Natl Cancer Inst Monogr; 1973 Dec; 39():115-9. PubMed ID: 4595311
    [No Abstract] [Full Text] [Related]

  • 20. An experimental model for immunotherapy of cancer.
    Zbar B, Ribi E, Rapp HJ.
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.